# VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial

Study · id `cardio:ct-nct01112917` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01112917](<https://clinicaltrials.gov/study/NCT01112917>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01112917

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 149 participants.

## Technical summary

Registry record NCT01112917. Allocation not applicable; no masking; primary purpose prevention. Start 2011-12 (registry gives no type); primary completion 2015-09 (actual). Results posted on 2016-07-11.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 149 participants (enrolled count; ClinicalTrials.gov record NCT01112917, source copy `cardio:ctgov-nct01112917-2016-07-11`, retrieved 2026-10-31)
- Start date: 2011-12 (registry gives no type) (ClinicalTrials.gov record NCT01112917, source copy `cardio:ctgov-nct01112917-2016-07-11`, retrieved 2026-10-31)
- Primary completion: 2015-09 (actual) (ClinicalTrials.gov record NCT01112917, source copy `cardio:ctgov-nct01112917-2016-07-11`, retrieved 2026-10-31)
- Completion: 2015-09 (actual) (ClinicalTrials.gov record NCT01112917, source copy `cardio:ctgov-nct01112917-2016-07-11`, retrieved 2026-10-31)
- Results first posted: 2016-07-11 (ClinicalTrials.gov record NCT01112917, source copy `cardio:ctgov-nct01112917-2016-07-11`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01112917, source copy `cardio:ctgov-nct01112917-2016-07-11`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01112917-2016-07-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
- Condition: Pulmonary Embolism
- Intervention (Device): VenaTech Convertible Vena Cava Filter
- Intervention (Procedure): Vena Cava Filter Conversion
- Lead sponsor: B. Braun Interventional Systems, Inc
- Lead sponsor class: INDUSTRY
- Collaborator: Bright Research Partners
- Collaborator class: INDUSTRY
- Collaborator: NAMSA
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as a collaborator: Bright Research Partners (`cardio:org-bright-research-partners`)

## Provenance

Content hash: 01486ec92a214f658140f8e9c731dcc52cd8b7bbe8d7c3ec437ea2a2b643944e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
